Home » Newsletters » BioWorld Science

BioWorld Science

March 6, 2020

View Archived Issues

New mouse model of MS reveals that oligodendroglia-specific connexin 47 regulates neuroinflammation

Matinas BioPharma initiates ENHANCE-IT study of MAT-9001

BioCryst initiates proof-of-concept trial of BCX-9930 in PNH

BITRAP demonstrates promising efficacy in preclinical models of rheumatoid arthritis

Servier publishes phase II data from RESTORE BRAIN study of S-44819

Phase I data for enzalutamide plus capivasertib in mCRPC

Enanta Pharmaceuticals patents MAP3K5 inhibitors

BenevolentAI Bio divulges new NTRK1 inhibitors

Blocking trash trashes MSI-hi tumors

Adlai Nortye describes hSTING receptor agonists

Il-Yang Pharmaceutical presents new antivirals

JAGUAHR Therapeutics patents new AhR antagonists

Indian approval of saroglitazar for noncirrhotic NASH

New gene fusion EWSR1-PATZ1 found in renal cell carcinoma

NCS-01 begins phase I/II study in patients with acute ischemic stroke

Enrollment open in phase I study of FT-596 for relapsed/refractory B-cell lymphoma or CLL

Gene therapy converts astrocytes into GABAergic neurons, alleviating motor deficits in HD models

Endocytosis inhibitor improves anticancer MAb efficacy

Gene rearrangements involving HMGA1/2 found in spindle cell/pleomorphic lipomas

Third cohort underway in phase I trial of Actimab-A plus CLAG-M for relapsed/refractory AML

Arcturus partners with Duke-NUS on COVID-19 vaccine development

Camrelizumab approved in China for advanced hepatocellular carcinoma

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...